Guillain-Barré Syndrome Diagnostics Market Expected to Reach USD 190.71 Million by 2034, Growing at a CAGR of 2.8%

The Guillain-Barre syndrome diagnostics market, in terms of revenue, was estimated to be worth USD 144.67 million in 2024. It is poised to reach USD 190.71 million by 2034, growing at a CAGR of 2.8% from 2025 to 2034.

What Is Guillain-Barre Syndrome Diagnostics?
Guillain-Barre syndrome is a condition in which the body's immunity attacks the nerves. It can cause numbness, weakness, or paralysis. The initial indications are weakness and tingling in the hands and feet. These sensations can swiftly advance and may cause paralysis. This syndrome is a medical exigency in which the majority of people require treatment in the hospital. Two-thirds of people have an indication of this infection in the six weeks prior to the symptoms commencing.

The healthcare expert may suggest a spinal tap, also known as a lumbar puncture, in which a small quantity of fluid is extracted from the spinal canal in the lower back. The fluid is examined for a kind of alteration that naturally takes place in people who suffer from Guillain-Barre syndrome. Also, electromyography (EMG) is suggested, where thin needle electrodes are thrust into the muscles to estimate nerve activity.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/guillain-barre-syndrome-diagnostics-market/request-for-sample

Who Are Market Key Players?
The firms are resolute in improving the preciseness of GBS diagnostics by progressing neurodiagnostic technologies and augmenting their product lines through consistent R&D endeavors. Market leaders are enumerated as follows:
• Alpine Biomed
• Bionen Medical Devices
• Cadwell Industries, Inc
• Deymed Diagnostic
• EMS Biomedical
• Medtronic plc
• Natus Medical Incorporated
• Neurosoft
• Nihon Kohden Corporation
• Rochester Electro-Medical, Inc.

Guillain-Barre Syndrome Diagnostics Market Report Highlights
• Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

• The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

• In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

• Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/guillain-barre-syndrome-diagnostics-market/request-for-discount-pricing

What are the Market Drivers?
Aging Population: The population more than 50 years old is surging. As per the World Bank Group, in 2023, 10% of the world's population exceeded 65 years of age. Aging causes a weaken immune system, making people more vulnerable to contamination. This escalates the probability of advancing Guillain-Barré syndrome, particularly succeeding viral or bacterial illness, placing the Guillain-Barre syndrome diagnostics market on a growth trajectory.

Growing Prevalence of Guillain-Barré Syndrome: The aggregate of Guillain-Barré syndrome (GBS) cases is surging worldwide. As per the World Health Organization, in 2023, the National Center for Epidemiology, Prevention, and Disease Control (CDC) of Peru announced epidemiological vigilance because of an instant surge in GBS cases in Peru.

How is Market Segmented?
The Guillain-Barre syndrome diagnostics market is segmented on the basis of test, end use, and region. Based on test, the lumbar puncture segment is anticipated to witness the fastest growth due to the test being important for validating the diagnosis, particularly when the indications are not clear.

Based on end use, the hospitals and clinics segment dominated the market in 2024 owing to the hospital having the necessary diagnostic instruments and professional healthcare experts to carry out tests such as lumbar punctures and nerve conduction inspection.

Global Guillain-Barre Syndrome Diagnostics Market, by Test
5.1. Key Findings
5.2. Introduction
5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
5.3. Lumbar Puncture
5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
5.4. Nerve Conduction
5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
5.5. Electromyography
5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
5.6. Other
5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

Global Guillain-Barre Syndrome Diagnostics Market, by End Use
6.1. Key Findings
6.2. Introduction
6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals and Clinics
6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
6.4. Diagnostic Laboratories
6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
6.5. Others
6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/guillain-barre-syndrome-diagnostics-market
How is the Region Bifurcated?
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

More Trending Latest Reports by Polaris Market Research:
Microcarriers Market
https://www.polarismarketresearch.com/industry-analysis/microcarriers-market

Metaverse in Healthcare Market
https://www.polarismarketresearch.com/industry-analysis/metaverse-in-healthcare-market

Synoptophore Market
https://www.polarismarketresearch.com/industry-analysis/synoptophore-market

Hereditary Testing Market
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.